2014 Grant Winners
EA|Quintiles and Illumina would like to thank those who participated in our 2014 Oncology Research Grant. This year’s grant was one of our most competitive, and we are pleased to announce this year’s grant recipients.» Read More
Genomics technology is transforming oncology treatment and drug development. The tools are now available to better understand the relationship between biomarkers and patient responses.
Quintiles has developed the Quintiles Comprehensive Cancer Panel (QCCP), a targeted sequencing assay for analysis of genomic variation correlated with response to available therapeutics and with response to marketed and experimental therapies in clinical trials.» Read More